Celldex Therapeutics, Inc. (NASDAQ:CLDX)

Major 2019 Biopharma Catalysts Coming in February and March

Biotech and pharmaceutical companies generally are involved in the lengthy process of getting their drug candidates to market through clinical trials. The amount of risk involved ranges from fair to ...
Read Full Story »

Ambev, Renren Slide into Friday’s 52-Week Low Club

June 22, 2018: Here are four stocks trading with heavy volume among 67 equities making new 52-week lows in Friday's session. On the NYSE advancers led decliners by about 2.11 ...
Read Full Story »

General Electric, Starbucks Drop into Thursday’s 52-Week Low Club

June 21, 2018: Here are four stocks trading with heavy volume among 86 equities making new 52-week lows in Thursday's session. On the NYSE decliners led advancers by about 2.04 ...
Read Full Story »

Oracle, Starbucks Plunge into Wednesday’s 52-Week Low Club

June 20, 2018: Here are four stocks trading with heavy volume among 60 equities making new 52-week lows in Wednesday's session. On the NYSE advancers led decliners by about 1.55 ...
Read Full Story »

Gogo, Tesaro Drop into Wednesday’s 52-Week Low Club

May 30, 2018: Here are four stocks trading with heavy volume among 67 equities making new 52-week lows in Wednesday's session. On the NYSE advancers led decliners by about 4.3 ...
Read Full Story »

JC Penney, Spectra Energy Slip into Tuesday’s 52-Week Low Club

May 22, 2018: Here are four stocks trading with heavy volume among 49 equities making new 52-week lows in Tuesday's session. On the NYSE decliners led advancers by about 1.58 ...
Read Full Story »

MGIC, Juniper Networks Slide into Wednesday’s 52-Week Low Club

April 18, 2018: Here are four stocks trading with heavy volume among 15 equities making new 52-week lows in Wednesday's session. On the NYSE advancers led decliners by about 8 ...
Read Full Story »

Celldex, Acacia Plummet into Monday’s 52-Week Low Club

April 16, 2018: Here are four stocks trading with heavy volume among 46 equities making new 52-week lows in Monday's session. On the NYSE advancers led decliners by about 11 ...
Read Full Story »

Why Celldex Therapeutics Is Getting Crushed

Celldex Therapeutics Inc. (NASDAQ: CLDX) shares were absolutely crushed on Monday morning after the firm announced results to its midstage breast cancer study. Specifically, the firm’s Phase 2b Metric Study ...
Read Full Story »

30 Big Biotech Events Coming in 2018

Over the past year, biotech companies have more or less kept pace with the markets, but they have the potential to break out in 2018. While they have been the ...
Read Full Story »

Top Analyst Upgrades and Downgrades: American Airlines, Boeing, Cabot Oil & Gas, Pandora, Southern Co., Vertex and Many More

Stocks were indicated to open higher yet again on Tuesday for all-time highs on the Dow and S&P 500. The one theme that has persisted through all the caution and ...
Read Full Story »

Macy’s, Tegna Drop into Tuesday’s 52-Week Low Club

June 6, 2017: Here are four stocks trading with heavy volume among 126 equities making new 52-week lows in Tuesday's session. On the NYSE, decliners led advancers by about 8 ...
Read Full Story »

Celldex Therapeutics Sinks Following ASCO Results

Celldex Therapeutics Inc. (NASDAQ: CLDX) was another big mover coming out of the Annual Meeting for the American Society of Clinical Oncology (ASCO). Unfortunately, the move was to the downside. ...
Read Full Story »
FDA_logo

Key FDA Decisions and Trial Results Expected in October

It is well known that U.S. Food and Drug Administration (FDA) rulings, along with the results from clinical trials, can make or break companies in the biotech and pharmaceutical industries. ...
Read Full Story »
FDA_logo

Key FDA Decisions and Trial Results Coming in the Next 2 Months

U.S. Food and Drug Administration (FDA) rulings and the results from clinical trials have proven time and again that they can make or break companies. The biotech and pharmaceutical ...
Read Full Story »